In osteosarcoma, accumulating data suggest a link between heightened CTLA-4 expression and disease progression (58), potentially mediated through mechanisms involving IDO induction, reduced T cell proliferation, and altered inflammatory cytokine signaling. Here, CTLA4 is linked to osteosarcoma.